Keywords: UK, NICE, Value-based medicines, Parliamentry inquiry, EMIG

EMIG calls for greater clarity on value-based medicines from UK Parliamentary inquiry into NICE

Article | 31 October 2012

The UK Ethical Medicines Industry Group (EMIG) has welcomed the House of Commons Health Select Committee’s inquiry into ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in